This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_NONHODGKIN_EXALLC for full statistics.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-9
200
Cancer registry: Topography ICD-O-3
ANY
Cancer registry: Morphology ICD-O-3
967[0-9]|970[0-2]
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
1110
Check minimum number of events None
1110
Include endpoints None
1110
Remove individuals based on genotype QC
1072
C3_NONHODGKIN
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Non-Hodgkin lymphoma, all
based on the number of shared cases.
Broader endpoints:
- Non-Hodgkin lymphoma, all (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1072 | 330 | 742 |
| Unadjusted prevalence (%) | 0.26 | 0.14 | 0.41 |
| Mean age at first event (years) | 69.27 | 67.27 | 70.17 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_NONHODGKIN – Non-Hodgkin lymphoma, all
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Non-Hodgkin lymphoma, all
↥Endpoint not on priority list, no data to show.